Your browser doesn't support javascript.
loading
Terapia trombolítica en TEP submasivo/riesgo intermedio: Evidencias y sugerencias post estudio Pulmonary Embolism Thrombolysis (PEITHO) / Thrombolytic therapy for submassive/ intermediate risk Pulmonary Embolism Evidence and suggestions after PEITHO trial
Marín V, Arnaldo; Gazmuri B, José Tomás; Andresen V, Max; Andresen, Max.
Affiliation
  • Marín V, Arnaldo; Universidad de Chile. Facultad de Medicina. Hospital Clínico de la Universidad de Chile. Santiago. CL
  • Gazmuri B, José Tomás; Universidad de Chile. Facultad de Medicina. Hospital Clínico de la Universidad de Chile. Santiago. CL
  • Andresen V, Max; Universidad de Chile. Facultad de Medicina. Hospital Clínico de la Universidad de Chile. Santiago. CL
  • Andresen, Max; Universidad de Chile. Facultad de Medicina. Hospital Clínico de la Universidad de Chile. Santiago. CL
Rev. méd. Chile ; 143(7): 895-904, jul. 2015. tab
Article in Es | LILACS | ID: lil-757915
Responsible library: CL1.1
ABSTRACT
Therapy for submassive pulmonary embolism (intermediate risk), remains controversial. New evidence has appeared that may help us in the process of decision making. We review the relevant literature, outline prognostic factors, and discuss current recommendations and controversies regarding the available alternatives such as systemic and catheter-directed thrombolytic use.
Subject(s)
Key words

Full text: 1 Index: LILACS Main subject: Pulmonary Embolism / Thrombolytic Therapy Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2015 Type: Article

Full text: 1 Index: LILACS Main subject: Pulmonary Embolism / Thrombolytic Therapy Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2015 Type: Article